Company / Total Debt
RHYTHM PHARMACEUTICALS, INC. Total Debt History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$100.9M
FY2025
5-year range
$100.9M / $108.3M
FY2023-FY2025
Trend
-6.8%
vs FY2024
Sector context
#57 of 83
Health Care
What the data says
At $101M, RHYTHM PHARMACEUTICALS, INC.'s total debt ranks #27 of 83 in the Health Care sector. Total Debt remained relatively stable over the past 3 years, with values between $101M and $108M.
Based on SEC 10-K filings.
$101M in FY2025.
Improved from $106M to $101M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#27 of 83 in Health CareTop 31% of 83This company $100.9M Sector average $6.2B
▼
-98.4% below sector average
Key checks
Key Insights
- In FY2025, total debt decreased 6.8% year-over-year.
- Ranks #57 out of 83 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -2.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $100.9M | -6.8% |
| FY2024 | $108.3M | +2.0% |
| FY2023 | $106.1M | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026